NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ian McLeodSVP CAO Treasurer2026-03-15781$14.20
$11.09kSell
Cheryl R. BlanchardDirector2026-03-1512,104$14.20
$171.88kSell
David ColleranEVP General Counsel Corp Sec2026-03-151,893$14.20
$26.88kSell
Ian McLeodSVP CAO Treasurer2026-03-141,449$14.20
$20.58kSell
David ColleranEVP General Counsel Corp Sec2026-03-144,168$14.20
$59.19kSell
Stephen D. GriffinPresident and CEO2026-03-145,944$14.20
$84.40kSell
Cheryl R. BlanchardDirector2026-03-1414,728$14.20
$209.14kSell
David ColleranEVP General Counsel Corp Sec2026-03-091,919$14.96
$28.71kSell
Ian McLeodSVP CAO Treasurer2026-03-09639$14.96
$9.56kSell
Cheryl R. BlanchardDirector2026-03-095,871$14.96
$87.83kSell

1 of 2

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.35%1,654,537$24.09MInstitution
Caligan Partners LP10.71%1,435,130$20.90MInstitution
Farmaceutici Spa Fidia10.61%1,422,384$20.71MInsider
Vanguard Group Inc5.81%779,165$11.34MInstitution
Morgan Stanley5.76%772,230$11.24MInstitution
Acadian Asset Management LLC4.53%606,544$8.83MInstitution
Boothbay Fund Management LLC3.99%534,507$7.78MInstitution
Renaissance Technologies LLC3.85%515,717$7.51MInstitution
Capital Management Corp3.73%500,465$7.29MInstitution
Dimensional Fund Advisors LP3.69%494,319$7.20MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK81.58%18.42%Net SellingNet Selling
ELMD34.45%65.55%Net Selling
LUCD18.19%23.75%Net Buying
QTRX64.33%35.67%Net BuyingNet Selling
SGHT36.19%57.63%Net BuyingNet Selling

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 91.46% institutional shareholders, 20.65% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 10.61% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $20.98M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.